ClaimsRay Kurzweil

“This is actually the very first time that this has happened.”

Ray Kurzweil, futurist, interviewee 9 July 2024 'The Singularity is Nearer,' Says Futurist Ray Kurzweil (Science Friday) archived copy

Factual Science and research methods

Simulated-biology-based trials of this kind have happened for the first time.

Unresolvable The public record could not settle it.

Factual: Statements about the present or the past, checked against the record: did they hold up?

The second judge would not resolve this claim; the verdict shown is the first judge's.

What would count as true or false

First identify, from the context of Kurzweil's 9 July 2024 remarks, the specific event he calls a first (for example a trial in which simulated biology replaced, or was formally accepted in place of, animal or human testing). True: as of July 2024 there is no documented earlier instance of the same kind of event. Mostly true: it is a first in the specific sense described, with only minor earlier precedents that differ in a significant qualifier (for example scope, regulator or type of product). Mixed: it is a first only under a narrow reading, while comparable instances clearly existed under a natural reading. Mostly false: documented earlier instances of essentially the same kind exist (for example the FDA's 2008 acceptance of the UVA/Padova type 1 diabetes simulator in place of animal trials, if that matches the event), but the event referred to was still notable or early. False: the evidence shows such trials had been done routinely or repeatedly well before, or that the event described did not happen.

Set before the research began.

Evidence (10)

  1. E1 Artificial Pancreas: The First 20 Years* - Francis J. Doyle, Boris P. Kovatchev, 2025 Journal of Diabetes Science and Technology (SAGE Publications) · 1 July 2025

    “In 2008, a computer simulator of the human metabolic system in T1D developed at the universities in Padova, Italy and Virginia, USA, and was accepted by the FDA as a substitute to animal trials in the testing of AID algorithms—this unprecedented event accelerated the AP development by years.”
  2. E2 The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day - PMC PubMed Central (Journal of Diabetes Science and Technology, 2018) · 16 February 2018

    “In particular, in 2008 the US Food and Drug Administration (FDA) accepted the T1D simulator developed by Universities of Virginia (UVA) and Padova as a substitute for preclinical trials for certain insulin treatments, including closed-loop algorithms for artificial pancreas (AP)”
  3. E3 The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day - PMC PubMed Central (Journal of Diabetes Science and Technology, 2018) · 16 February 2018

    “The upgrades to the previous simulator, which was accepted by the Food and Drug Administration in 2013, are described.”
  4. E4 The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day - PMC PubMed Central (Journal of Diabetes Science and Technology) · 16 February 2018

    “In particular, in 2008 the US Food and Drug Administration (FDA) accepted the T1D simulator developed by Universities of Virginia (UVA) and Padova as a substitute for preclinical trials for certain insulin treatments, including closed-loop algorithms for artificial pancreas (AP).”
  5. E5 Artificial Pancreas: The First 20 Years* - Francis J. Doyle, Boris P. Kovatchev, 2025 SAGE Publications (Journal of Diabetes Science and Technology) · July 2025

    “In 2008, a computer simulator of the human metabolic system in T1D developed at the universities in Padova, Italy and Virginia, USA, and was accepted by the FDA as a substitute to animal trials in the testing of AID algorithms—this unprecedented event accelerated the AP development by years.”
  6. E6 The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day - PMC PubMed Central (Journal of Diabetes Science and Technology) · 16 February 2018

    “A first update of the simulator (S2013) was released and accepted by FDA in 2013, which incorporated a nonlinear glucose response to hypoglycemia and a model of counterregulation.”
  7. E7 Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility Journal of Diabetes Science and Technology (SAGE) · 25 September 2023

    “In January 2008, in an unprecedented decision, the Food and Drug Administration (FDA) accepted this simulator as a substitute to animal trials for the pre-clinical testing of insulin treatment strategies.”
  8. E8 Clinical trials without humans – why computer simulations could make drugs a lot cheaper - University of Liverpool News University of Liverpool News (republished from The Conversation) · 24 August 2022

    “In 2008, the FDA approved one such trial to replace the use of dogs when testing insulin control loops in type 1 diabetes (a device that lets an insulin pump communicate with a continuous glucose monitor).”
  9. E9 Clinical trials without humans – why computer simulations could make drugs a lot cheaper - University of Liverpool News University of Liverpool News (republished from The Conversation) · 24 August 2022

    “Instead, the evidence from the in silico clinical trial was accepted by the US Food and Drug Administration (FDA) and the device was approved.”
  10. E10 Ray Kurzweil explains how AI makes radical life extension possible Freethink · 9 July 2024 Own record

    “by the end of this decade, we will be able to start the process of augmenting and ultimately replacing slow, underpowered human trials with digital simulations.”

Reasoning

The evidence shows the FDA accepted the UVA/Padova simulator in place of animal trials in 2008 [E1][E7][E8], and that a device was approved on in silico trial evidence [E9]. The criteria first require identifying the event Kurzweil called a first, and the material does not establish what that event was or that it matches these earlier instances, so it cannot settle the claim.

Cite this claim

Ray Kurzweil, “Simulated-biology-based trials of this kind have happened for the first time.” (said 9 July 2024). Verdict: unresolvable. Reliability API, claim c_1ed689717ed9, method 0.1.0+28da144b, dataset release v1.1.2. https://epistacklabs.com/claims/c_1ed689717ed9

This claim is in dataset release v1.1.2, with the same verdict.

Reply to this claim

For Ray Kurzweil, or someone speaking for them: a correction or counter-evidence. Replies are read before anything is shown; an approved reply shows your name, role, date, statement and link. Your email address is never shown and is deleted 30 days after the decision (privacy).

More factual claims by Ray Kurzweil

  1. Mostly false Factual 9 July 2024
    “Right now, you’re getting back about four months a year.”

    Currently scientific progress gives back about four months of life expectancy per year.

  2. Mostly false Factual 9 July 2024
    “And then AlphaFold 2 in 2022 went through 200 million proteins and got the shape exactly correct, and that’s going to help come up with new medications.”

    AlphaFold 2 in 2022 went through 200 million proteins and got their shapes exactly correct, which will help produce new medications.

  3. Resolved true Factual 9 July 2024
    “As of two or three years ago, we had gone through 170,000 proteins.”

    As of two or three years ago, 170,000 proteins had been worked through by people.

  4. Mixed Factual May 2020
    “The current method for testing these few treatments is to organize a few hundred human subjects and then test them over about a year and a half, at a cost of hundreds of millions of dollars.”

    The current method for testing the few treatments that are tried organizes a few hundred human subjects and tests them over about a year and a half, at a cost of hundreds of millions of dollars.

  5. Mostly true Factual May 2020
    “Very often, the first several solutions tested on humans are not ideal and lead to other solutions that also take a few years to develop and test.”

    Very often the first several solutions tested on humans are not ideal and lead to other solutions that also take a few years to develop and test.

All of them

Verdicts are made automatically; how verdicts are made.